Felodipine extended-release tablets are suitable for people with elevated systolic blood pressure.
Felodipine extended-release tablets belong to dihydropyridine calcium channel antagonist, can inhibit the inward flow of extracellular calcium ions, thus inhibiting the contraction of vascular smooth muscle, dilate blood vessels, so that the peripheral vascular resistance decreased and lead to a reduction in blood pressure. By dilating coronary blood vessels and reducing the workload of the heart to play an anti-angina effect.
Felodipine extended-release tablets are clinically used in the treatment of patients with hypertension, coronary heart disease and stable angina pectoris. The treatment effect on many types of hypertension is relatively good, in addition, it also has a mild sodium and diuretic effect. Its antihypertensive effect has a rapid onset of action, antihypertensive efficacy and antihypertensive amplitude is relatively strong, and can be used in combination with antihypertensive drugs such as β-blockers, diuretics, or angiotensin-converting enzyme inhibitors, and can also have an anti-atherosclerotic effect when taken over a long period of time.
Felodipine extended-release tablets may cause accelerated heart rate, facial flushing, headache, ankle edema and other symptoms, usually can be relieved by themselves to disappear. Acute myocardial infarction, pregnant women, decompensated heart failure, unstable angina pectoris, severe hepatic impairment is prohibited. Use with caution in those with aortic stenosis, hepatic impairment, severe renal impairment, and heart failure after acute myocardial infarction.
During the administration of felodipine extended-release tablets, attention should be paid to monitoring the patient’s blood pressure to prevent postural hypotension, avoid eating grapefruit or grapefruit juice during the period of administration of the drug, and also must avoid excessive alcohol consumption.
Specific use should be consulted with the doctor and taken as prescribed.